CDR-Life
PrivateLast Round
Series A
Apr 13, 2022
Total Funding Raised
$88.7M
Company Overview
CDR-Life is a biotechnology company that develops tumor-selective immunotherapies using its proprietary M-gager® antibody technology to target intracellular antigens for cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CDR-Life Comparables
Compare CDR-Life with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Clasp Therapeutics | 81% | |
| Gilead Sciences | 81% | |
| EvolveImmune Therapeutics | 81% |
CDR-Life Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 13, 2022 | ||||
| Seed | May 11, 2021 |
Key People
Founding team and executive leadership
CDR-Life Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series A |
| Omega Funds | Series A |
| Jeito Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 3, 2026
Dimitrios Chondros appointed as the new Chief Medical Officer.
- Nov 4, 2025
Global licensing agreement for trispecific antibody CDR111 with Boehringer Ingelheim.
CDR-Life Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CDR-Life's valuation, stock price, and market status.
Is CDR-Life a public or private company?
CDR-Life is a private company.
What is the current stock price of CDR-Life?
CDR-Life is a private company with no public stock price. No recent secondary market data is available.
How much is CDR-Life worth (valuation)?
Valuation information for CDR-Life is not publicly available.
Can I buy CDR-Life stock?
CDR-Life shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CDR-Life's last funding round?
CDR-Life's most recent funding round was Series A on April 13, 2022.
Who are the main investors in CDR-Life?
Key investors in CDR-Life include RA Capital Management, Jeito.
Will CDR-Life IPO soon?
No public IPO plans have been announced for CDR-Life.
How can I track CDR-Life secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CDR-Life's secondary market activity and sign up for updates.